Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
biOasis Technologies Ord Shs
BIOAF
Primary Symbol:
V.BTI.H
Healthcare
Biotechnology
Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in...
particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:BTI.H)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(2261)
•••
Boomskid
X
View Profile
View Bullboard History
Comment by
Boomskid
on Jun 21, 2023 6:58pm
RE:RE:RE:RE:Is There a Case Against xB3?
Yeah, they care, beenthere. Your opinion doesn't matter on this one. jd
(306)
•••
beenthere
X
View Profile
View Bullboard History
Comment by
beenthere
on Jun 21, 2023 6:55pm
RE:RE:RE:Is There a Case Against xB3?
Doesn't matter who they are directed at! They don't care about your opinion and I sure wished I hadn't! But that's water until the bridge now isn't it? As for walking good for
...more
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 24, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(2261)
•••
Boomskid
X
View Profile
View Bullboard History
Comment by
Boomskid
on Jun 21, 2023 5:14pm
RE:RE:Is There a Case Against xB3?
I do understand, beenthere, that you and many others don't understand why I'm posting and towards whom my posts are actually directed. But then, I wonder why you take the time to read them
...more
(306)
•••
beenthere
X
View Profile
View Bullboard History
Comment by
beenthere
on Jun 21, 2023 4:52pm
RE:Is There a Case Against xB3?
jd: There is no publicly know serious case against xB3. I think it likely that xB3 is OK and that lots of money will be made from it. SO WHAT! So what if you are right? Means
...more
(2261)
•••
Boomskid
X
View Profile
View Bullboard History
Comment by
Boomskid
on Jun 21, 2023 4:38pm
RE:RE:Reasons Why Pharmas May Have Avoided Bioasis
I completely agree with this post by prophetoffactz. His post will have at least one thumb. jd
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Jun 21, 2023 4:30pm
RE:Reasons Why Pharmas May Have Avoided Bioasis
If you are going to partner with a company it's nice to know that it's going to be around. Biotech is a long-term game. BTI has never been adequately capitalized and has a history of
...more
(2261)
•••
Boomskid
X
View Profile
View Bullboard History
Comment by
Boomskid
on Jun 21, 2023 4:23pm
RE:RE:The xB3 Patents
Hey, zwerp, Lind isn't going to buy the patents. They've already paid for them. All that's left for them is to claim the patents through foreclosure . Then they're sell the patents
...more
(2261)
•••
Boomskid
X
View Profile
View Bullboard History
Post by
Boomskid
on Jun 21, 2023 4:13pm
Reasons Why Pharmas May Have Avoided Bioasis
Some people seem to think that the only explanation for the lack of xB3 deals might be a failure of xB3. Here are some others. First, we've had 3 CEOs in 6 years. That indicates trouble
...more
(40)
•••
zwerp2000
X
View Profile
View Bullboard History
Comment by
zwerp2000
on Jun 21, 2023 3:43pm
RE:The xB3 Patents
yes, everyone will be rushing to buy these worthless patents for a worthless technology. you live in a fantasy world. is it because you can't fathom how badly you got this wrong and how much time
...more
(2261)
•••
Boomskid
X
View Profile
View Bullboard History
Post by
Boomskid
on Jun 21, 2023 3:23pm
The xB3 Patents
Will the xB3 patents soon be owned by an anonymous company out of the Cayman Islands or somewhere else offshore? Did you notice that there were offshore players among the placees in the
...more
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Jun 21, 2023 3:23pm
RE:Is There a Case Against xB3?
xB3 has been given three management teams in addition to Medimmune, Prothena, Vaccinex, and Chiesi to find a path forward. There was Biodexa and Cresence. Many other companies have looked at xB3. It
...more
(40)
•••
zwerp2000
X
View Profile
View Bullboard History
Comment by
zwerp2000
on Jun 21, 2023 3:16pm
RE:RE:And I agree with craighenry about xb3...it does not work
LOL, yeah, sure....sure. Whatever you say
(2261)
•••
Boomskid
X
View Profile
View Bullboard History
Comment by
Boomskid
on Jun 21, 2023 3:08pm
RE:RE:Is There a Case Against xB3?
Oh, I understand, zwerp. You don't want me to comment about your comments about my comments about your comments about my comments about your comments about my comments about your
...more
(2261)
•••
Boomskid
X
View Profile
View Bullboard History
Comment by
Boomskid
on Jun 21, 2023 2:59pm
RE:And I agree with craighenry about xb3...it does not work
We understand, zwerp, that you cannot understand that the payloads may also fail. Bioasis has never taken the risk of proving xB3 in a preclinical study. Why would any pharma make a deal with Bioasis
...more
(40)
•••
zwerp2000
X
View Profile
View Bullboard History
Post by
zwerp2000
on Jun 21, 2023 2:27pm
And I agree with craighenry about xb3...it does not work
If it did, someone would have come forward to use it. Cheisi looked at it and then dropped it. Prothena worked with it and then gave up. No one else saw any value to it to scoop this company up for at
...more
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >